Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 May 28;1(1):vdz004. doi: 10.1093/noajnl/vdz004

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 3 — Effects of PI3K and mitogen-activated protein kinase (MEK) inhibition. Representative blots for SU-DIPG-IV cells treated with ZSTK474, trametinib, or their combination (A). Semi-quantification of pAKT (B) and pERK (C) as protein expression fold-change over 0.1% DMSO vehicle. Representative blots for SU-DIPG-XIII cells treated with ZSTK474, trametinib, or their combination (D). Semi-quantification of pAKT (E) and pERK (F) as protein expression fold-change over 0.1% DMSO vehicle. One-way t tests were conducted against fold-change of 1, *P < .05, **P < 0.01, ***P < .001. Error bars SEM.